LMNTD2-AS1

Across TCGA pan-cancer cohorts, LMNTD2-AS1 RNA is linked to patient survival in 26 of 34 cancer types, making it the most broadly survival-associated LMNTD2-AS1 data layer.

The strongest signal is observed in colon adenocarcinoma (COAD), where higher LMNTD2-AS1 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated LMNTD2-AS1 expression acts as an unfavorable survival marker, although some lineages such as BRCA and SKCM show a favorable association.

COAD, ACC, and LGG are the cancer types where LMNTD2-AS1 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
COAD	OS	Tertile	All	0.471	0.675	<.001	65	view →
ACC	DFS	Median	All	0.329	0.757	<.001	58	view →
LGG	DFS	Median	All	0.266	0.475	<.001	46	view →
UVM	DFS	Tertile	III,IV	0.240	0.780	.006	39	view →
KICH	DFS	Tertile	III,IV	0.234	0.885	.003	36	view →
KIRC	DFS	Tertile	All	0.462	0.697	.001	34	view →
BRCA	OS	Tertile	All	0.959	0.912	.008	32	view →
PRAD	DFS	Median	All	0.819	0.942	<.001	30	view →
SKCM	OS	Tertile	All	0.836	0.749	.005	18	view →
MESO	OS	Quartile	All	0.757	0.385	.004	12	view →
STAD	OS	Median	II,III,IV	0.651	0.461	.012	10	view →
BLCA	OS	Tertile	II,III,IV	0.780	0.647	.011	9	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 26 lineages.

LMNTD2-AS1–COAD (OS)

Open the COAD breakdown →